Mylan launches generic Apresoline injection

PITTSBURGH —  Mylan recently launched its generic Apresoline (hydralazine HCl) injection. The 20-mg/ml injection is indicated to treat  severe hypertension in cases where a drug can’t be given orally or in cases where a patient has an urgent need to lower blood pressure. 

 

The treatment had U.S. sales of about $63.4 million in the 12 months ended March 21, according to Mylan.